« Return to News | Drug Sponsors

Shanghai Pharmaceuticals inks $3 billion in overseas contracts

Thursday, April 14, 2011 01:07 PM

Shanghai Pharmaceuticals will ink more than $3.06 billion worth of procurement contracts with 69 worldwide pharmaceutical companies this year, according to Global Times.

Pfizer, Sanofi-Aventis, Merck and Novo Nordisk are just a few involved, and the contracts are estimated to account for approximately 60% of Shanghai Pharmaceuticals' total procurement of drugs and medical devices.

Li Yongzhong, vice president of Shanghai Pharmaceuticals, said that the company hopes to double its volume of business with overseas pharmaceutical companies in the future.

"Our value-added support is a big help for those overseas drug makers who can greatly benefit from the growing Chinese market," an officer surnamed Lu from the office of the board of directors of Shanghai Pharmaceuticals told the Global Times. "With our domestic resources, we can provide market entry support for new medicines, winning government tenders, relevant policy information, new product registration, and all other related fields."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.